SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation
K. Schmidt, A. Schmidt, S. Gross, A. Just, A. Pfanne, M. Fuchs, M. Jordan, E. Mohr, A. Pich, J. Fiedler, T. Thum
This study shows SGLT2 inhibitors reduce endothelial to mesenchymal transition and cardiac fibroblast activation through effects on mitochondrial respiration, actin cytoskeleton, and specific transporters.
bioRxiv · Dec 18, 2023Pharmacology & Toxicology